Michelle Rempel announces an investment of $2,983,800 for a new Metabolomics Technology Demonstration Centre, in partnership with Genome Alberta, and the University of Alberta.
Left to right: Dr. Walter Dixon, Associate Vice-President of Research and Professor of Biochemistry, University of Alberta; Dr. Pamela Valentine, Chief Partnership Officer, Alberta Innovates Health Solutions; Dr. David Bailey, President and CEO, Genome Alberta; Dr. David Wishart, Professor, Departments of Biological Sciences and Computing Science, University of Alberta; Michelle Rempel, Minister of State, Western Economic Diversification; Dr. Pierre Meulien, President and CEO, Genome Canada; and Dr. Richard Fedorak, President, Metabolomic Technologies Inc.
Minister Rempel speaks with Dr. David Wishart (left) and program coordinator, Tamara Lim (centre), during the lab tour at the University of Alberta.
Minister Rempel tours Dr. David Wishart’s lab at the University of Alberta.
The Government of Canada is strengthening Alberta’s position as a global leader in the emerging metabolomics market thanks to an investment that will enable Genome Alberta, together with the University of Alberta, to establish the Metabolomics Technology Demonstration Centre. News Release >